top of page


Pharmexsys typically works with emerging ($5–$25M) and mid size ($100M–$500M) companies in the pharmaceutical, life science and healthcare related industries. We are actively involved in business plan development and fundraising initiatives through angel investors and venture capital firms.

Richard Khazzaka

Director of Supply Chain, Alexion

“I worked with Ross and had nothing but good results. He is knowledgeable, hardworking and will be an asset for any organization that needs his expertise.”

Kurt Brenkus

CEO, Aver Informatics

“Ross is a deeply strategic thinker. He is a polished executive that has helped guide our startup through all aspects of our business plan and model to prepare us for market. An authentic, warm, and firm demeanor, Ross has quickly established rapport with our executive leadership and board members. It is an absolute pleasure working with Ross. I give him my highest recommendation.”

Dan Jessup

Exec V.P., Jones, Lang, LaSalle

“It was a pleasure working with Ross regarding a distribution center lease renewal and expansion. He was very professional and knowledgeable. Once given the background information and market statistics, Ross made the required decisions with clarity and efficiency. He had an excellent understanding regarding the dynamics surrounding the transaction and used this knowledge to proceed with conviction.”

Kwasi Mensah

Senior Director, Supply Chain Management, Relypsa Inc.

“The Pharmexsys team helped me build an effective end-to-end supply chain for the launch of Veltassa."

Tom Doyle

Exec. VP, Specialty Solutions, H.D. Smith

“Ross and his team were excellent partners as we developed our strategic plan.”

Roger Maffia

VP, Trade Horizon Pharmaceuticals

"Pharmexsys was an excellent choice to streamline our 3PL RFP process.  The analysis was excellent, resulting in saving money and seamless consolidation of our 3PL partners.”

Please reload

Need more details? Contact us

We are here to assist. Contact us by phone, email or via our Social Media channels.

bottom of page